*Data were recorded at time of presentation to hospital or at time of stroke if already an inpatient. † Four patients in hospital at the time of stroke were not included; four other patients were transferred from another hospital (time to arrival at initial hospital was used in these cases). ‡ Sixteen patients underwent intravenous therapy prior to endovascular therapy; time parameters were recorded in 14. Letter to the editor trials (2, 8) . Furthermore, our study included patients with posterior territory stroke, which were not included in MR CLEAN, EXTEND-IA, ESCAPE, or MR RESCUE, although they were included in IMS III and SYNTHESIS (1) (2) (3) (4) (5) (6) . Stratification of our results showed these patients had poorer outcomes compared with anterior circulation vessel occlusion ( Table 3) . A number of factors may contribute to differences in outcomes including variability of interventional radiologist experience and time from stroke onset to treatment initiation. In our patient group, the mean time from stroke onset to arrival at hospital was 59 minutes. This was better than the mean of 78 minutes in EXTEND-IA (2). Our mean time to initiation of intravenous thrombolysis was 123 minutes, which compares with 127 in EXTEND-IA, 122·4 in IMS III, 110 in ESCAPE, and 85 in MR CLEAN (1) (2) (3) 6) . Mean time to the commencement of endovascular therapy was 235 minutes in our study, 210 min in EXTEND-IA, and 260 minutes in MR CLEAN (1) (2) (3) .
Given the recently published evidence supporting endovascular therapy (8), we suggest it is important to report outcomes from past 'real-world experience' which in comparison with current evidence demonstrates why the initial studies were negative. Translation of the current evidence to our stroke services is now the critical step for best clinical outcomes. Letter to the editor
